Evidence map›Paper›PMID 38241065›Full record

ArticleJMIR diabetes2024

Effects of Digitization of Self-Monitoring of Blood Glucose Records Using a Mobile App and the Cloud System on Outpatient Management of Diabetes: Single-Armed Prospective Study.

Tomoko Handa, Takeshi Onoue, Tomoko Kobayashi, Ryutaro Maeda, Keigo Mizutani, Ayana Yamagami, Tamaki Kinoshita, Yoshinori Yasuda, Shintaro Iwama, Takashi Miyata and 10 more

Open access · goldAbstract read
In one paragraph

Article in JMIR diabetes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Blood Glucose Monitoring Expert Group and Best Practice Recommendation-FITTER BiG.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Tomoko HandaDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0003-3729-9512
Takeshi OnoueDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0002-8589-9937
Tomoko KobayashiDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0003-3151-1287
Ryutaro MaedaDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0009-0001-1406-1408
Keigo MizutaniDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0009-0007-4264-0259
Ayana YamagamiDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0001-5894-5945
Tamaki KinoshitaDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0001-9933-0306
Yoshinori YasudaDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0003-0674-2956
Shintaro IwamaDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0002-3281-0337
Takashi MiyataDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0002-1479-2251
Mariko SugiyamaDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0001-6289-1249
Hiroshi TakagiDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0003-3954-792X
Daisuke HagiwaraDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0002-4353-231X
Hidetaka SugaDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0003-1924-7639
Ryoichi BannoResearch Center of Health, Physical Fitness and Sports, Nagoya University, Nagoya, Japan.ORCID https://orcid.org/0000-0002-8546-1636
Yoshinori AzumaDepartment of Endocrinology and Diabetes, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.ORCID https://orcid.org/0009-0008-5064-4767
Takatoshi KasaiDepartment of Endocrinology and Metabolism, Tosei General Hospital, Seto, Japan.ORCID https://orcid.org/0009-0003-2170-2239
Shuko YoshiokaDepartment of Endocrinology and Metabolism, Tosei General Hospital, Seto, Japan.ORCID https://orcid.org/0009-0006-4226-7119
Yachiyo KuwatsukaDepartment of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.ORCID https://orcid.org/0000-0001-6092-3948
Hiroshi ArimaDepartment of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0003-3746-1997
Nagoya University · JPTosei General Hospital · JPJapanese Red Cross Nagoya Daini Hospital · JPNagoya University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years, technologies promoting the digitization of self-monitoring of blood glucose (SMBG) records including app-cloud cooperation systems have emerged. Studies combining these technological interventions with support from remote health care professionals have reported improvements in glycemic control.

objectiveTo assess the use of an app-cloud cooperation system linked with SMBG devices in clinical settings, we evaluated its effects on outpatient management of diabetes without remote health care professional support.

methodsIn this multicenter, open-label, and single-armed prospective study, 48 patients with diabetes (including type 1 and type 2) at 3 hospitals in Japan treated with insulin or glucagon-like peptide 1 receptor agonists and performing SMBG used the app-cloud cooperation system for 24 weeks. The SMBG data were automatically uploaded to the cloud via the app. The patients could check their data, and their attending physicians reviewed the data through the cloud prior to the patients' regular visits. The primary outcome was changes in glycated hemoglobin (HbA

resultsAlthough HbA

conclusionsThe digitization of SMBG records and sharing of the data by patients and attending physicians during face-to-face visits improved self-management in patients with diabetes.

trial registrationJapan Registry of Clinical Trials (jRCT) jRCTs042190057; https://jrct.niph.go.jp/en-latest-detail/jRCTs042190057.

Indexed as

appdiabetesdiabetes caredigital interventiondigital therapeuticsglycemic controlmHealthmobile app

Identifiers

PMID38241065
PMCPMC10837757
OpenAlexW4391024262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.